Glaxo revamps sales rep compensation as part of an effort to compete in the cancer market - STAT

Glaxo revamps sales rep compensation as part of an effort to compete in the cancer market - STAT

STAT Plus: Glaxo revamps sales rep compensation as part of an effort to compete in the cancer market

By ED SILVERMAN

KIRSTY WIGGLESWORTH/AP

The change comes as Glaxo attempts to compete in the burgeoning oncology market and also underscores an attempt to revamp the company more broadly.

READ MORE